Orgenesis Inc. Business Finance Contracts & Agreements
127 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (5)
- Escrow Agreements (1)
- Exchange Agreements (7)
- Investment Agreements (1)
- Loan Agreements (24)
- Note Agreements (14)
- Purchase Agreements (16)
- Registration Rights Agreements (5)
- Release Agreements (1)
- Shareholders Agreements (1)
- Stock Agreements (2)
- Subscription Agreements (18)
- Term Sheets (3)
- Waiver Agreements (1)
- Warrant Agreements (27)
- Promissory Note, dated as of November 4, 2024, by and between Orgenesis Maryland LLC, the Company and Jacob Safier (Filed With SEC on November 5, 2024)
- Loan Agreement, dated as of October 31, 2024, by and between Koligo Therapeutics, Inc., the Company and Yehuda Nir (Filed With SEC on November 5, 2024)
- Loan Extension Agreement, dated as of October 31, 2024, by and between Koligo Therapeutics, Inc., the Company and Yehuda Nir (Filed With SEC on November 5, 2024)
- Amended and Restated Promissory Note, dated as of August 23, 2024, by and between Orgenesis Maryland LLC, Jacob Safier and Orgenesis Inc (Filed With SEC on August 26, 2024)
- Form of Warrant to be issued to Jacob Safier (Filed With SEC on August 26, 2024)
- Asset Purchase Agreement, dated as of July [12], 2024, among Orgenesis Inc., Theracell Advanced Biotechnology S.A, Theracell Advanced Biotechnology LTD and IDNA Genomics Public... (Filed With SEC on July 12, 2024)
- Asset Purchase Agreement, dated as of July 10, 2024, between Orgenesis Inc. and Broaden Bioscience and Technology Corp (Filed With SEC on July 12, 2024)
- Loan Agreement dated July 3, 2024, by and among the Borrower and Yehuda Nir (Filed With SEC on July 8, 2024)
- Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yosef Dotan (Filed With SEC on May 23, 2024)
- Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Aharon Lukach (Filed With SEC on May 23, 2024)
- Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yehuda Nir (Filed With SEC on May 23, 2024)
- Asset Purchase and Strategic Collaboration Agreement, dated as of April 5, 2024, between Orgenesis Maryland LLC and Griffin Fund 3 BIDCO, Inc (Filed With SEC on April 11, 2024)
- Securities Purchase Agreement, dated March 3, 2024, by and among the Company and the Investors (Filed With SEC on March 7, 2024)
- Form of March 2024 Warrant with $2.00 exercise price (Filed With SEC on March 7, 2024)
- Form of March 2024 Warrant with $1.50 exercise price (Filed With SEC on March 7, 2024)
- Binding Term Sheet, dated as of February 26, 2024, between Orgenesis Maryland LLC and Germfree Laboratories LLC (Filed With SEC on March 1, 2024)
- Unit Purchase Agreement, dated as of January 29, 2024, between the Company and MM OS Holdings L.P (Filed With SEC on January 31, 2024)
- Term Sheet, dated as of January 18, 2024, between the Company and MM OS Holdings L.P (Filed With SEC on January 24, 2024)
- Amendment Agreement, dated as of January 16, 2024, to Securities Purchase Agreement, dated November 8, 2023, by and among the Company and the November 2023 Investor (Filed With SEC on January 22, 2024)
- Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Aharon Lukach (Filed With SEC on January 5, 2024)
- Loan Extension Agreement, dated as of January 1, 2024, by and between the Company and Yehuda Nir (Filed With SEC on January 5, 2024)
- Form of Lukach Warrant, dated as of January 1, 2024 (Filed With SEC on January 5, 2024)
- Form of Nir Warrant, dated as of January 1, 2024 (Filed With SEC on January 5, 2024)
- Convertible Loan Agreement dated September 29, 2023, by and among the Borrower and Sai Traders (Filed With SEC on November 13, 2023)
- Securities Purchase Agreement, dated August 31, 2023, by and among the Company and a certain investor (Filed With SEC on November 13, 2023)
- Form of Securities Purchase Agreement, dated November 8, 2023, by and between Orgenesis Inc. and the Investor (Filed With SEC on November 8, 2023)
- Form of Warrant (Filed With SEC on November 8, 2023)
- Convertible Loan Agreement dated September 29, 2023, by and among the Borrower and Sai Traders (Filed With SEC on October 5, 2023)
- Securities Purchase Agreement, dated August 31, 2023, by and among the Company and the Investor (Filed With SEC on September 1, 2023)
- Amendment No. 2 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P (Filed With SEC on July 7, 2023)
- Amendment No. 1 to Unit Purchase Agreement dated as of May 5, 2023 by and among Orgenesis Inc., Morgenesis LLC and MM OS Holdings, L.P (Filed With SEC on May 10, 2023)
- Convertible Loan Agreement, dated March 27, 2023, by and among the Borrower and Yehuda Nir (Filed With SEC on March 31, 2023)
- Form of Securities Purchase Agreement between the Company and the Purchaser, dated February 23, 2023 (Filed With SEC on February 24, 2023)
- Form of Warrant (Filed With SEC on February 24, 2023)
- Convertible Loans and Unsecured Convertible Notes Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yehuda Nir (Filed With SEC on January 18, 2023)
- Convertible Credit Line Extension Agreement, dated as of January 12, 2023, by and between the Company and Aharon Lukach (Filed With SEC on January 18, 2023)
- Convertible Credit Line and Unsecured Convertible Note Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yosef Dotan (Filed With SEC on January 18, 2023)
- Convertible Loan Agreement, dated January 10, 2023, by and among the Company and Ariel Malik (Filed With SEC on January 13, 2023)
- Convertible Loan Agreement, dated January 10, 2023, by and among the Company and NewTech Investment Holdings, LLC (Filed With SEC on January 13, 2023)
- Form of Warrant (Filed With SEC on January 13, 2023)
